It also contributes to preeclampsia by binding to the 3′UTR of TGFβ [222] and plays an anti-cancer role in several cancers, namely ovarian cancer by targeting PAK3 [223], breast cancer by regulating MORC4 [224], and urothelial cancer by targeting ETS1 and Cyclin D1 [225]. Here, CCND1 is linked to cancer.